Go Ad-Free
logoThe People's Perspective on Medicine

Antidepressants Reduce Tamoxifen Effectiveness

Tamoxifen is an important drug to prevent recurrence of breast cancer, but a new study shows it should not be taken in conjunction with certain antidepressants. Roughly 1,300 women were followed for one year. Sixteen percent of those taking antidepressants such as Prozac, Paxil and Zoloft had a recurrence during that time. Those who were not taking antidepressants had a recurrence rate of 7.5 percent.

The scientists have an explanation for why Prozac, Paxil and Zoloft might be interfering with tamoxifen’s effectiveness. The antidepressants inhibit an enzyme (CYP2D6) that activates the anti-cancer drug. Other antidepressants that don’t affect this enzyme would be a much better choice as they appear unlikely to interact with tamoxifen. Such antidepressants include Effexor, Lexapro, Luvox and Celexa. About half a million women in the U.S. take tamoxifen to prevent breast cancer recurrence and about a third of them are prescribed antidepressants. The FDA is considering changing the label to warn doctors about this potentially deadly interaction.

Rate this article
5- 1 rating
About the Author
Joe Graedon is a pharmacologist who has dedicated his career to making drug information understandable to consumers. His best-selling book, The People’s Pharmacy, was published in 1976 and led to a syndicated newspaper column, syndicated public radio show and web site. In 2006, Long Island University awarded him an honorary doctorate as “one of the country's leading drug experts for the consumer.”.
Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Browse our website ad-free
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.